85 related articles for article (PubMed ID: 17579235)
21. Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth.
Chollet A; Mori G; Menendez C; Rodriguez F; Fabing I; Pasca MR; Madacki J; Korduláková J; Constant P; Quémard A; Bernardes-Génisson V; Lherbet C; Baltas M
Eur J Med Chem; 2015 Aug; 101():218-35. PubMed ID: 26142487
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of prolipoprotein signal peptidase by globomycin.
Dev IK; Harvey RJ; Ray PH
J Biol Chem; 1985 May; 260(10):5891-4. PubMed ID: 3888977
[TBL] [Abstract][Full Text] [Related]
23. Identification and heterologous expression of the globomycin biosynthetic gene cluster.
Oves-Costales D; Gren T; Sterndorff EB; Martín J; Ortiz-López FJ; Jørgensen TS; Jiang X; Román-Hurtado F; Reyes F; Genilloud O; Weber T
Synth Syst Biotechnol; 2023 Jun; 8(2):206-212. PubMed ID: 36844473
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of an essential mycobacterial cell wall lipase (Rv3802c) as tuberculosis drug leads.
West NP; Cergol KM; Xue M; Randall EJ; Britton WJ; Payne RJ
Chem Commun (Camb); 2011 May; 47(18):5166-8. PubMed ID: 21384024
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein Signal Peptidase Inhibitors with Antibiotic Properties Identified through Design of a Robust In Vitro HT Platform.
Kitamura S; Owensby A; Wall D; Wolan DW
Cell Chem Biol; 2018 Mar; 25(3):301-308.e12. PubMed ID: 29337186
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.
Johnston KL; Wu B; Guimarães A; Ford L; Slatko BE; Taylor MJ
Parasit Vectors; 2010 Oct; 3():99. PubMed ID: 20946650
[TBL] [Abstract][Full Text] [Related]
27. Identification of two Mycobacterium smegmatis lipoproteins exported by a SecA2-dependent pathway.
Gibbons HS; Wolschendorf F; Abshire M; Niederweis M; Braunstein M
J Bacteriol; 2007 Jul; 189(14):5090-100. PubMed ID: 17496088
[TBL] [Abstract][Full Text] [Related]
28. Mycobacterium tuberculosis surface protein Rv0227c contains high activity binding peptides which inhibit cell invasion.
Rodríguez DM; Ocampo M; Curtidor H; Vanegas M; Patarroyo ME; Patarroyo MA
Peptides; 2012 Dec; 38(2):208-16. PubMed ID: 23000473
[TBL] [Abstract][Full Text] [Related]
29. Association of the Rv0679c protein with lipids and carbohydrates in Mycobacterium tuberculosis/Mycobacterium bovis BCG.
Matsuba T; Suzuki Y; Tanaka Y
Arch Microbiol; 2007 Apr; 187(4):297-311. PubMed ID: 17252234
[TBL] [Abstract][Full Text] [Related]
30. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
[TBL] [Abstract][Full Text] [Related]
31. Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2.
Gavrish E; Sit CS; Cao S; Kandror O; Spoering A; Peoples A; Ling L; Fetterman A; Hughes D; Bissell A; Torrey H; Akopian T; Mueller A; Epstein S; Goldberg A; Clardy J; Lewis K
Chem Biol; 2014 Apr; 21(4):509-518. PubMed ID: 24684906
[TBL] [Abstract][Full Text] [Related]
32. Effect of natural amphipathic peptides on viability, membrane potential, cell shape and motility of mollicutes.
Béven L; Wróblewski H
Res Microbiol; 1997 Feb; 148(2):163-75. PubMed ID: 9765797
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Mycobacterium tuberculosis secretory serine protease blocks bacterial multiplication both in axenic culture and in human macrophages.
Upadhye V; Majumdar A; Gomashe A; Joshi D; Gangane N; Thamke D; Mendiratta D; Harinath BC
Scand J Infect Dis; 2009; 41(8):569-76. PubMed ID: 19479636
[TBL] [Abstract][Full Text] [Related]
34. [Inhibitory effects of 10-23 deoxyribozyme targeting ICL gene on the expression of isocitrate lyase and the infection of Mycobacterium tuberculosis in macrophages].
Li JM; Li N; Zhu DY; Yi ZJ; Liu YH; Yang C; He YL
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):531-5. PubMed ID: 17074266
[TBL] [Abstract][Full Text] [Related]
35. Targeting mycobacterial proteolytic complexes with natural products.
Parish T
Chem Biol; 2014 Apr; 21(4):437-438. PubMed ID: 24766844
[TBL] [Abstract][Full Text] [Related]
36. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
Zerbini E; Andreu D; Tonarelli G; Sequeira MD
Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and evaluation of small molecule reactive oxygen species generators as selective Mycobacterium tuberculosis inhibitors.
Dharmaraja AT; Alvala M; Sriram D; Yogeeswari P; Chakrapani H
Chem Commun (Camb); 2012 Oct; 48(83):10325-7. PubMed ID: 22977884
[TBL] [Abstract][Full Text] [Related]
38. 2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1.
Neres J; Hartkoorn RC; Chiarelli LR; Gadupudi R; Pasca MR; Mori G; Venturelli A; Savina S; Makarov V; Kolly GS; Molteni E; Binda C; Dhar N; Ferrari S; Brodin P; Delorme V; Landry V; de Jesus Lopes Ribeiro AL; Farina D; Saxena P; Pojer F; Carta A; Luciani R; Porta A; Zanoni G; De Rossi E; Costi MP; Riccardi G; Cole ST
ACS Chem Biol; 2015 Mar; 10(3):705-14. PubMed ID: 25427196
[TBL] [Abstract][Full Text] [Related]
39. Proteases in Mycobacterium tuberculosis pathogenesis: potential as drug targets.
Roberts DM; Personne Y; Ollinger J; Parish T
Future Microbiol; 2013 May; 8(5):621-31. PubMed ID: 23642117
[TBL] [Abstract][Full Text] [Related]
40. A new 2-carbamoyl pteridine that inhibits mycobacterial FtsZ.
Reynolds RC; Srivastava S; Ross LJ; Suling WJ; White EL
Bioorg Med Chem Lett; 2004 Jun; 14(12):3161-4. PubMed ID: 15149666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
